Duquesne Family Office »

Cidara Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 50k 220.89

More positions owned by Duquesne Family Office

Natera (NTRA)
Select Sector Spdr Tr State Street Fin (XLF)
Insmed Com Par $.01 (INSM)
Ishares Msci Brazil Etf (EWZ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Woodward Governor Company (WWD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coupang Cl A (CPNG)
Alphabet Cap Stk Cl A (GOOGL)
Sea Sponsord Ads (SE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
MercadoLibre (MELI)
Bbb Foods Cl A Com (TBBB)

View all positions for Duquesne Family Office

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics